Rx (Prescription Medicine)
USD $ 10.00
Letronat 2.5mg Tablet 是一种主要用于治疗绝经后女性激素受体阳性乳腺癌的药物。其活性成分为 Letrozole，属于非甾体芳香化酶抑制剂。它通过阻断酶 aromatase 的活性，使其无法将雄激素转化为雌激素。通过降低体内雌激素水平，Letronat 有助于减缓或阻止依赖雌激素生长的乳腺癌细胞增殖。
该药物通常作为早期或晚期乳腺癌治疗方案的一部分。常规剂量为每日口服一片 2.5mg Tablet，可与食物同服或空腹服用。您的医生会根据您的个体反应及癌症分期决定治疗时长。
Letronat 2.5mg Tablet 的常见不良反应可能包括潮热、关节痛、疲劳、恶心和头痛。虽然罕见但可能出现更严重的不良反应，因此如有任何疑虑，请及时与您的医疗提供者讨论。请将药片存放于室温，避免潮湿和高温，并置于儿童不易触及的地方。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Letrozole 2.5 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
